Speakers you need to see at DeviceTalks Minnesota

A Google executive whose own heart problems spurred her to seek medtech innovation, a leader at Abbott who wants to drive healthcare value, the head of an upstart company seeking to transform diabetes care — those are but some of the speakers you will encounter at DeviceTalks Minnesota this June.

Read on to find out more about some of the top speakers we’ve lined up for the show. And register soon to attend.

Next>>

Attend DeviceTalks Minnesota, June 4–5 in St. Paul>>

The post Speakers you need to see at DeviceTalks Minnesota appeared first on MassDevice.

How Bigfoot Biomedical’s CEO wants to boost diabetes management

Jeffrey Brewer faced the biggest challenge of his life when his 7-year-old son Sean received a diabetes diagnosis in 2002: Diabetes became the new focus for Brewer’s energy.

In his role as CEO at JDRF (formerly the Juvenile Diabetes Research Foundation) between 2011 and 2014, Brewer forged financial partnerships with industry to drive the development of insulin delivery and glucose monitoring technologies. He joined the founding of Bigfoot Biomedical in 2014 because he felt that industry could and should do more to marry the best of our technologies to automate diabetes management and make them available to the greatest number of people in need.

Get the full story at our sister site, Medical Design & Outsourcing.

Brewer returns for a keynote appearance at DeviceTalks Minnesota, June 4–5 in St. Paul, Minn.

The post How Bigfoot Biomedical’s CEO wants to boost diabetes management appeared first on MassDevice.

Bigfoot Biomedical CEO hits back against CMS over data-sharing decision

Share

Bigfoot BiomedicalBigfoot Biomedical CEO Jeffrey Brewer has spoken out about a recent data-sharing decision made by CMS, saying that he plans to lobby Medicare to reverse its latest move.

Earlier this year, CMS said it would begin covering the use of particular continuous glucose monitors for people with diabetes. But since that decision, the agency has said that if a beneficiary uses a non-durable medical equipment device, like a smartphone, separately or in combination with a device classified as DME, it will not be reimbursed.

In other words, according to Brewer, Medicare will not reimburse for ‘s (NSDQ:DXCM) G5 smartphone app. The chief executive said that people who use Dexcom’s glucose monitor have reported that they can’t use the company’s share function that allows a family member or another person to remotely monitor the user’s glucose levels.

Get the full story at our sister site, Drug Delivery Business News.

Bigfoot compares trial data with modeling results for automated insulin delivery system

  • How a versatile epoxy is enabling brain stimulation

    Rohit Ramnath, Senior Product Engineer, Master Bond In but another example of how useful and critical epoxies can be, researchers in Israel used a two-part epoxy to construct a magnetic coil to stimulate animal brain neurons via a magnetic field. Designers of medical electronics assemblies have many options to choose from when selecting one or […]

  • Pros and cons of MDNR and MDMA medical device registration in Saudi Arabia

    By Stewart Eisenhart, Emergo Group Now that Saudi Arabian medical device regulators have exempted some low-risk products from full registration requirements, qualifying manufacturers should consider whether standard or fast-track access to the Saudi market best suits their business needs. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog […]

  • How middleware is changing medtech

    Medtech developers can take advantage of middleware technology to gain a competitive advantage. By Tim Gee, principal of Medical Connectivity Two macro trends are affecting how medical devices and systems are designed: Adoption of off-the-shelf (OTS) computing technology to extend the power and capabilities of traditional embedded system medical devices; and the evolution of software […]

  • How have medtech launches and prototyping evolved with 3D printing?

    Here are three basic ways that 3D printing can help you get your medical device project off the ground. Jim Medsker, Keystone Solutions Group Additive manufacturing, commonly referred to as 3D printing, began to surface in the 1980s. Since then, the technology has quickly become a valuable tool for creating plastic prototype parts in a rapid […]

  • Appirio launches solutions for Salesforce Lightning Bolt

    Wipro company Appirio recently launched new solutions that are built on Salesforce Lightning to deliver personalized and industry-specific services. The solutions that the company is ordering are all Lightning Bolts which are frameworks that allow companies to create functional and customer-facing websites. It is designed to increase collaboration and communication during crucial interaction points while […]

  • Sterigenics parent company is now Sotera Health

    Sterigenics International said today that it has changed the name of its parent company to Sotera Health, with Nelson Labs, Nordion and Sterigenics as Sotera’s three operating companies. The new name drew its inspiration from the name of the Greek goddess of safety, Soteria, and is meant to reflect the company’s commitment to global health. […]

  • Scapa Healthcare introducing new ultra-flexible silicone gel adhesive

    Scapa Healthcare – maker of skin-friendly adhesives – will introduce its new ultra-flexible Scapa Soft-Pro Silicone Gel 6058 at the 2017 Medica Trade Fair, Nov. 13–16 in Düsseldorf, Germany. The Silicone Gel 6058 is the most flexible silicone in Scapa’s product portfolio, according to the Windsor, Conn.–based company. It is conformable and contours to challenging anatomical […]

  • Chesapeake IRB, Schulman IRB merge to form Advarra

    Chesapeake IRB and Schulman IRB have merged to form Advarra, a new provider of IRB, institutional biosafety committee (IBC) and research compliance services. “By coming together as Advarra, we are merging the highest quality review organizations in the industry,” Jeffrey Wendel, president and CEO of Chesapeake IRB said. “Through a customer-centric integration, we will be […]

  • Greenlight Guru adds Grow to quality management software platform

    Greenlight Guru recently announced the introduction of its Grow software product to assist medical device companies with quality management after product launch. The Indianapolis-based company’s first product, Go, focused on helping medtech companies utilize design control, risk management and document management software to bring FDA and ISO-compliant medical devices to market in less time. Many […]

  • Enhancing catheter steerability and deflection

    It’s all in the tip when it comes to making catheters with state-of-the-art steerability and deflection. Andy Black and Tanner Hargens, Medical Murray Steerable catheters Catheters often need to navigate tortuous anatomy with precise control of the catheter tip. Steerable catheters are often utilized for access into side branches from parent vessels to introduce guidewires […]

  • Report: Q3 medical device recalls down 39%

    Medical device recalls have declined 39% for the third quarter, settling at 167, the lowest quarter the US has seen since the fourth quarter of 2011, according to a new Stericycle Expert Solutions report. Recalled units were up, however, rising 1% to 68 million which positioned it higher than 16 of the last 19 quarters, […]

  • Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problem

    Bigfoot BiomedicalBigfoot Biomedical‘s chief executive is excited about Abbott‘s (NYSE:ABT) latest regulatory win – and it’s not just because the two companies have an established partnership.

    Yesterday, the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring system. It’s the first device of its kind, allowing patients to track their blood glucose levels without the use of routine finger sticks.

    “It’s a tremendous demonstration that the FDA understands the value of factory calibration and making usage of a sensor simpler and easier,” Bigfoot CEO Jeffrey Brewer told Drug Delivery Business News.

    Get the full story at our sister site, Drug Delivery Business News.

    The post Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problem appeared first on MassDevice.